Serum Chief executive officer Adar Poonawalla says the company has entered into an exclusive agreement with US-based Visterra for developing a dengue antibody.
first published: Sep 22, 2015 04:54 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty to test 26,000-mark on monthly expiry day | Opening Bell

LIVE: Moneycontrol Mutual Fund Summit 2025 |Bengaluru| Decoding Purpose, Products, Tech

Nifty, Sensex Gain On Easing US–China Trade Tensions, Fed Rate Cut Hopes | Closing Bell

Live: Nifty enters busy Q2 earnings week, FOMC meeting | Opening Bell
You are already a Moneycontrol Pro user.

